Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IGSF9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SEC22C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK32A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC729083 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101930655 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST8SIA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRNE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRD7P3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANGPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL6A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETDB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF563 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928580 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDKN2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZDHHC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNRC18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD300LB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on